<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One of the most common skeletal affections in humans is <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e>, a <z:hpo ids='HP_0008873'>short-limbed dwarfism</z:hpo> that is, in most cases, caused by mutations in the transmembrane domain of the fibroblast growth factor receptor-3 (FGFR-3) gene </plain></SENT>
<SENT sid="1" pm="."><plain>Due to the lack of sufficient radiological, genetic, and molecular studies, most types of <z:hpo ids='HP_0000924'>skeletal anomalies</z:hpo> in dogs are classified as <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>To initiate the molecular characterization of some osteochondrodysplastic dog breeds, we obtained the DNA sequence of the transmembrane domain of the FGFR-3 gene from the dachshund, basset hound, bulldog, and German shepherd dogs </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 4 breeds showed no mutation in the evaluated region </plain></SENT>
<SENT sid="4" pm="."><plain>This indicates that the mutation responsible for the osteochondrodysplastic phenotype in the tested dog breeds lies either elsewhere in the FGFR-3 gene or in other ones involved in the formation and development of endochondral bone </plain></SENT>
</text></document>